Skip to main content
NASDAQ:TCON

TRACON Pharmaceuticals SEC Filings & 10K Form

$6.13
+0.32 (+5.51 %)
(As of 05/14/2021 03:43 PM ET)
Add
Compare
Today's Range
$5.87
$6.17
50-Day Range
$5.67
$9.01
52-Week Range
$1.55
$12.20
Volume1,338 shs
Average Volume385,172 shs
Market Capitalization$95.03 million
P/E RatioN/A
Dividend YieldN/A
Beta2.02

SEC Filings

TRACON Pharmaceuticals (NASDAQ:TCON) SEC Filings

DateFilerForm TypeView
05/05/2021
4:16 PM
TRACON Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/23/2021
3:24 PM
TRACON Pharmaceuticals (Filer)
Form DEFA14A
04/23/2021
3:12 PM
TRACON Pharmaceuticals (Filer)
Form DEF 14A
03/15/2021
3:37 PM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2021
8:40 PM
New Enterprise Associates 14, L.P. (Filed by)
TRACON Pharmaceuticals (Subject)
Form SC 13D/A
03/09/2021
5:00 AM
Brown Scott B. (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
3:50 PM
Johnson-Pratt Lisa (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
3:48 PM
Johnson-Pratt Lisa (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/08/2021
7:14 AM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2021
4:26 PM
TRACON Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/25/2021
4:20 PM
TRACON Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2021
3:11 PM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2021
2:09 PM
683 Capital Management, LLC (Filed by)
TRACON Pharmaceuticals (Subject)
Form SC 13G/A
02/16/2021
7:33 AM
Ikarian Capital, LLC (Filed by)
TRACON Pharmaceuticals (Subject)
Form SC 13G/A
02/12/2021
4:20 PM
Opaleye Management Inc. (Filed by)
TRACON Pharmaceuticals (Subject)
Form SC 13G/A
02/09/2021
2:17 PM
Linden Capital L.P. (Filed by)
TRACON Pharmaceuticals (Subject)
Form SC 13G/A
02/02/2021
3:39 PM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2021
5:00 AM
THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
7:12 AM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/30/2020
5:24 PM
Chart Westcott Living Trust (Reporting)
Ikarian Capital, LLC (Reporting)
Ikarian Healthcare Fund GP, L.P. (Reporting)
Ikarian Healthcare Master Fund, L.P. (Reporting)
Shahrestani Neil (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2020
5:00 AM
TRACON Pharmaceuticals (Issuer)
WIGGINS MARK C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2020
5:00 AM
THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2020
7:21 AM
TRACON Pharmaceuticals (Filer)
Form 424B5
12/29/2020
7:11 AM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2020
8:53 AM
Opaleye Management Inc. (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2020
7:22 AM
TRACON Pharmaceuticals (Filer)
Form 424B5
12/22/2020
7:16 AM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/09/2020
4:15 PM
TRACON Pharmaceuticals (Filer)
Form 424B5
12/09/2020
4:11 PM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2020
5:18 PM
Chart Westcott Living Trust (Reporting)
Ikarian Capital, LLC (Reporting)
Ikarian Healthcare Fund GP, L.P. (Reporting)
Ikarian Healthcare Master Fund, L.P. (Reporting)
Shahrestani Neil (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/10/2020
4:02 PM
TRACON Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2020
3:19 PM
TRACON Pharmaceuticals (Filer)
Form DEF 14A
10/23/2020
8:30 PM
Opaleye Management Inc. (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2020
5:00 AM
THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/20/2020
3:14 PM
TRACON Pharmaceuticals (Filer)
Form PRE 14A
09/25/2020
8:30 PM
Opaleye Management Inc. (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2020
5:00 AM
THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/21/2020
7:30 AM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2020
8:22 PM
Chart Westcott Living Trust (Reporting)
Ikarian Capital, LLC (Reporting)
Ikarian Healthcare Fund GP, L.P. (Reporting)
Ikarian Healthcare Master Fund, L.P. (Reporting)
Shahrestani Neil (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4/A
09/17/2020
8:19 PM
Chart Westcott Living Trust (Reporting)
Ikarian Healthcare Fund GP, L.P. (Reporting)
Ikarian Healthcare Master Fund, L.P. (Reporting)
Shahrestani Neil (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/16/2020
3:32 PM
TRACON Pharmaceuticals (Filer)
Form 424B3
09/15/2020
8:19 PM
Ikarian Capital, LLC (Reporting)
Ikarian Healthcare Master Fund, L.P. (Reporting)
Shahrestani Neil (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2020
5:49 PM
Ikarian Capital, LLC (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/14/2020
4:00 PM
Ikarian Capital, LLC (Filed by)
TRACON Pharmaceuticals (Subject)
Form SC 13G
09/14/2020
12:49 PM
TRACON Pharmaceuticals (Issuer)
WIGGINS MARK C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2020
11:15 PM
TRACON Pharmaceuticals (Filer)
Form EFFECT
09/09/2020
5:15 PM
Opaleye Management Inc. (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2020
5:00 AM
THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2020
8:24 PM
TRACON Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/03/2020
4:15 PM
Opaleye Management Inc. (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2020
8:40 PM
Opaleye Management Inc. (Filed by)
TRACON Pharmaceuticals (Subject)
Form SC 13G
08/31/2020
8:36 PM
Opaleye Management Inc. (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2020
8:33 PM
Opaleye Management Inc. (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/31/2020
7:13 AM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2020
7:18 AM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/25/2020
5:00 AM
THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2020
5:06 AM
THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2020
7:28 PM
THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2020
7:17 PM
THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2020
4:23 PM
TRACON Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/03/2020
1:30 PM
TRACON Pharmaceuticals (Filer)
Form CT ORDER
07/09/2020
11:16 PM
TRACON Pharmaceuticals (Filer)
Form EFFECT
06/25/2020
4:46 PM
THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
4:32 PM
LARUE WILLIAM R (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
4:31 PM
MATTINGLY MARTIN A (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
4:30 PM
TRACON Pharmaceuticals (Issuer)
Twiford J Rainer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
4:29 PM
TRACON Pharmaceuticals (Issuer)
WORLAND STEPHEN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
4:27 PM
TRACON Pharmaceuticals (Issuer)
Walker Paul Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
4:24 PM
PELLETIER SAUNDRA L (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2020
7:40 AM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2020
4:21 PM
TRACON Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2020
3:44 PM
TRACON Pharmaceuticals (Filer)
Form DEFA14A
04/24/2020
7:30 AM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2020
4:16 PM
TRACON Pharmaceuticals (Filer)
Form PRE 14A
03/19/2020
7:30 AM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2020
5:21 PM
THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2020
5:02 PM
THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
3:13 PM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2020
7:15 AM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2020
3:12 PM
Brown Scott B. (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
3:11 PM
TRACON Pharmaceuticals (Issuer)
WIGGINS MARK C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
3:10 PM
THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
3:10 PM
TRACON Pharmaceuticals (Issuer)
WIGGINS MARK C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
3:09 PM
Brown Scott B. (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2020
3:08 PM
THEUER CHARLES (Reporting)
TRACON Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
3:01 PM
Linden Capital L.P. (Filed by)
TRACON Pharmaceuticals (Subject)
Form SC 13G/A
01/13/2020
7:20 AM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
7:01 AM
TRACON Pharmaceuticals (Filer)
Form 424B5
12/20/2019
6:14 AM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2019
9:47 AM
Puissance Capital Fund LLC (0001695347) (Reporting)
Puissance Capital Management LP (Reporting)
Puissance Cross-Border Opportunities IV LLC (Reporting)
Puissance Cross-Border Opportunities V LLC (Reporting)
TRACON Pharmaceuticals (Issuer)
Wang Theodore T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2019
3:52 PM
TRACON Pharmaceuticals (Filer)
Form 424B3
11/25/2019
3:18 PM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/24/2019
11:15 PM
TRACON Pharmaceuticals (Filer)
Form EFFECT
11/12/2019
3:43 PM
TRACON Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/06/2019
4:08 PM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2019
3:18 PM
TRACON Pharmaceuticals (Filer)
Form DEF 14A
10/21/2019
7:20 AM
TRACON Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2019
4:02 PM
TRACON Pharmaceuticals (Filer)
Form PRE 14A
10/08/2019
11:15 PM
TRACON Pharmaceuticals (Filer)
Form EFFECT
10/03/2019
3:34 PM
TRACON Pharmaceuticals (Filer)
Form S-3/A
This page was last updated on 5/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.